NLRP3 and myocardial infarction: This suggests that beyond the time of treatment and potentially differential effect on the pace of the clock, Rev-erbα-regulated inhibition of NLRP3 before or at reperfusion may hold promise to reduce myocardial I/R damages, whenever the time at which the patient will undergo cardiac surgery or experience MI.